For: | Kristo I, Riss S, Argeny S, Maschke S, Chitsabesan P, Stift A. Incidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease. World J Gastroenterol 2017; 23(3): 472-477 [PMID: 28210083 DOI: 10.3748/wjg.v23.i3.472] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i3/472.htm |
Number | Citing Articles |
1 |
Vasiliki Gkretsi, Lefteris C. Zacharia, Triantafyllos Stylianopoulos. Targeting Inflammation to Improve Tumor Drug Delivery. Trends in Cancer 2017; 3(9): 621 doi: 10.1016/j.trecan.2017.07.006
|
2 |
Iago Rodríguez-Lago, Javier P Gisbert. The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn’s Disease. Journal of Crohn's and Colitis 2020; 14(4): 557 doi: 10.1093/ecco-jcc/jjz158
|
3 |
Michael J. Grieco, Feza H. Remzi. Management of Inpatient Inflammatory Bowel Disease. 2022; : 133 doi: 10.1007/978-1-0716-1987-2_7
|
4 |
|
5 |
Bo Shen, Gursimran Kochhar, Udayakumar Navaneethan, Francis A Farraye, David A Schwartz, Marietta Iacucci, Charles N Bernstein, Gerald Dryden, Raymond Cross, David H Bruining, Taku Kobayashi, Martin Lukas, Amandeep Shergill, Martin Bortlik, Nan Lan, Milan Lukas, Shou-Jiang Tang, Paulo Gustavo Kotze, Ravi P Kiran, Parambir S Dulai, Sandra El-Hachem, Nayantara Coelho-Prabhu, Shyam Thakkar, Ren Mao, Guodong Chen, Shengyu Zhang, Begoña González Suárez, Yago Gonzalez Lama, Mark S Silverberg, William J Sandborn. Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. The Lancet Gastroenterology & Hepatology 2020; 5(4): 393 doi: 10.1016/S2468-1253(19)30366-8
|
6 |
Paulina Núñez F, Rodrigo Quera, David T Rubin. Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget. World Journal of Gastrointestinal Endoscopy 2022; 14(2): 85-95 doi: 10.4253/wjge.v14.i2.85
|